Arkan Ventures has announced a new Digital Health Roundtable Series designed to create a structured forum for investors, practitioners, and innovators to examine the evolving role of technology in healthcare delivery and financing. The series aims to convene family offices, digital health operators, thematic specialists, and ESG-aligned allocators for facilitated discussions on capital deployment, sector trends, and the structural conditions shaping care at scale.
Each session in the series will be grounded in Environmental, Social, and Governance (ESG) frameworks and aligned with specific United Nations Sustainable Development Goals. The targeted goals are SDG 3 (Good Health and Well-being), SDG 9 (Industry, Innovation and Infrastructure), and SDG 17 (Partnerships for the Goals). The firm has explained that all discussion themes will be mapped to relevant SDG indicators to ensure conversations remain anchored to measurable outcomes rather than broad aspirations.
The roundtable series is currently in development, with the first sessions anticipated for later in 2026. Each convening is expected to follow a structured half-day format that combines a keynote perspective from a digital health operator or clinician with facilitated investment dialogue among participants. Thematic sessions under consideration include AI-assisted diagnostics and care delivery, interoperable health data and infrastructure, and the financing of equitable telehealth access in underserved communities.
Chris Marcoux, Chief Communications Officer at Arkan Ventures, said the initiative reflects a broader recognition that family offices and impact-aligned investors frequently lack structured access to curated deal flow and peer-level dialogue in the digital health space. "We want to increase the space for this kind of dialogue so that digital health technology can be more widely understood," Marcoux explained.
Arkan Ventures is currently seeking contributors to participate in the roundtable series in the coming year. The firm is inviting digital health founders, healthcare investors, and subject-matter experts—including clinicians, technologists, and policy practitioners—to contribute their perspectives and help shape the agenda across sessions. Sessions will be invitation-based and thematically focused, with participants engaging with ESG measurement methodologies aligned to the SDG Impact Standards. This approach provides a consistent framework through which healthcare allocations can be assessed for both financial and social performance.
The development of this series comes at a time when technology's role in healthcare continues to expand, yet significant gaps remain in how investment capital flows toward solutions that address both health outcomes and social impact. By creating a structured dialogue that connects capital with innovation through established impact frameworks, Arkan Ventures aims to address what Marcoux identified as a lack of structured access for certain investor groups. Final session dates and topics will be confirmed as the program takes shape throughout the development phase.
